The stock market rally showed strength on Fed chief Jerome Powell, but a hot jobs report pared gains. The S&P 500 is fighting for its 200-day. Read More...
Motley Fool
3 Growth Stocks That Are Too Cheap to Ignore
The stock market hates uncertainty, and the global factors driving the market in 2022 have understandably left many investors feeling frustrated. While no one can predict when this volatile period will wrap up, the history of the stock market has shown that patient investors who maintain stakes in great businesses can sustain and compound rewarding returns with time. Currently, the company relies on its portfolio of cystic fibrosis (CF) medicines to drive revenue and profits, and it continues to deliver on both fronts year after year.
Add Comment